Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Locking in gains is always good. who knows what tomorrow will bring, but today, we know you got near 30% on it. Fantastic!
IDRA - Added 1,000 at $3.31 - AVG now $3.98 w/ 2,000 shares. Will look to add 1,000 more perhaps.
Status Filled at $3.31
Symbol IDRA
Description IDERA PHARMACEUTICALS INC COM NEW
Action Buy
Quantity 1,000 Shares
Route FDLM
Order Type Limit at $3.31
Order Date 04/24/2014, 02:12:39 PM ET
Cancel Date
Order Number D24KPCD
Fantastico! Lock in gains, lock in gains. that's the only way to actually get gains :)
I played it once before in December I think. At this moment, I'm only planning on averaging down on the ones that I'm holding, before dipping toes in new ones. That can change at any moment. But, that's my plan.
good job horent. keep watching and playing it :)
Thanks. Am going to watch it for a little bit, see if it pulls back and then may enter if cash is available. Much appreciated.
thank you. If you get a chance, let us know when you enter/exit. Would like to learn.
SYN - Watching IBB to see if it falls to 200DMA around 221 and bounces. I may add to SYN near those levels, or just ride with what I have.
CYTR $3.12 - Gap to fill - For those watching CYTR, just keep in mind, that it's fallen alot, and there's a gap nearby at $2.60ish. If still watching and waiting, might be worth it to wait some more and see if it fills the gap first.
QRXPY - I don't know enough about the company overall to make a suggestion either way. If I believed in the company and they had additional items in their pipeline, then I'd look more into a technical play with it.
I typically don't make technical chart plays on ones that have tanked bad, if I didn't believe in owning the company overall. Even if the chart has a great play, I figure ...just to buy off technicals isn't worth it for me. It may very well bounce back, just not my kinda thing.
Just my $.02
VGZ NonBio - mattchew - I put VGZ away in my 2nd tier of watchlist stocks. The chart is starting to look interesting to me. Was VGZ just a chart that you found interesting or do you know more about the company and catalysts?
Thanks,
note to hesse - if you still own it or know more about it, please let me know.
Chart looks like it has good support around the $.46 area. May be worth a play from $.46 to $.58. But I need to find out more info about it.
OT: Going to Cubs 100th anniversary of Wrigley Field Game today. When your team hasn't won a world series in over 100 years, you celebrate things like a stadium being old and ...
the first 2-Day winning streak all year! (last two days).
Taking my 74 year old dad. Going to be 44 degrees, no sun and I'm sure cold wind off the lake in a concrete building - baseball in April in Chicago, no hope, no sun, no wins, but they're giving away cupcakes today :) and jerseys.
It teaches you to appreciate other things then wins and losses. There's always next year.
SYN $3.03 - I was very close to adding more SYN on the dip with IBB this AM, but I'll be out soon for the rest of the day so can't watch the IBB close enough. I was down $3,800 on SYN two weeks ago, but believed in catalysts, down $450 now.
Holding 4,000 shares @ $3.13 - and still believing. Am looking to hold through data of early next week for a decent pop.
Welcome - I'd like to do more, just am limited at the moment. Hope to get back to what's "normal" for me soon.
Speculation is good :) Thanks smurf.
SYN - Cancelled Equity Agreement - Interesting
I'm not exactly sure what this means, but it looks positive to me. SYN cancelled an agreement to raise more money. Maybe they didn't like the terms, maybe...they have a different agreement coming, maybe...dunno really. Info to think about...
link: http://ih.advfn.com/p.php?pid=nmona&article=61917315
On April 18, 2014, Synthetic Biologics, Inc. (the “Company”) delivered written notice to Cantor Fitzgerald & Co. that it was terminating its Controlled Equity OfferingSM Sales Agreement, dated July 3, 2013, and amended on December 11, 2013, (the “Agreement”), pursuant to Section 12(b) of the Agreement, effective as of the close of business on April 28, 2014. No shares were offered or sold pursuant to the Agreement, and the offering facility is no longer available for use.
---------------------------------------------
Also... from iHub Poster Ann1 on the iHub SYN board - Longtime SYN Investor/Supporter (from what I've read in the past)
link: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=100935927
Good day, everyone! Are we having fun yet?!!
It takes cash to commercialize product and yet, SYN just cancelled an equity agreement. Why do you think that is? ???
There must be plans to make some money. A partnership or buyout perhaps? A placement (PIPE or otherwise) for far more money due to the impending PPS increase after Trimesta results?!
Any way you slice it, THIS cancellation combined with the recent stock options and salary increases bode very well for SYN. I have lots of confidence on this one. LOTS.
They are dropping the crumbs. Hansel and Gretel just have to pick them up!
OT: Research - I have a lot of research to do for the markets overall and for the Bio Sector. As we know, the Bios have made a fantastic reversal the last few days, and I'm just trying to get back to break even for the month. If possible, get a little extra. I know many are in the same boat as me. I believe they were over-extended moving down, so a bounce up was expected for those that held, but how much is the question.
hesse posted some good info, and there's also other good posts that I found recently about the Biotech sector that I'll re-post soon. I think one of the best reasons for believing this bounceback, are the mergers and acquisitions that are being mentioned over the news. Perhaps that means that companies are undervalued and/or more properly valued? But is it a dead-cat bounce or ???
Since I'm behind on charting, and tracking upcoming catalysts and such, I'm only focused on the moment on averaging down, or selling current holdings. As I did with ETRM, I may do with other positions. When I average down, I'm not looking for big gains, I'm entering again right before what I think will be a short-term fast spike up, then take what it gives and get out. Losing $500 is better than losing $2,000.
Today I sold ETRM when the IBB peaked in early AM around 235, then slipped down to 233-234. ETRM held for a few minutes around $1.92-$1.94, before it followed down. I figured ETRM's catalyst isn't until mid June, and that's too far out right now. ETRM ended down $.01 for the day at $1.81. It certainly can fly a LOT higher, but not losing is winning for me right now.
Remember to share strategies and ideas, that's why we are here. To learn from each other (and hopefully make $). I'm still dealing with spine/nerve issues, but that's my distraction, and we all have some type of distraction to deal with.
Best of Luck to all.
SYN $2.97 - Nice call Norm. Let's hope it continues up a bit before data release. Would be nice to see it nearer $3.40 before then.
ETRM - Sold @ $1.92 - Profit +$134.92
I averaged down on ETRM two weeks ago and that worked well for me. With the IBB rebound and it's catalyst in June (ADCOM), I took this opportunity to get out with a very small profit. Considering I was down $2,000 on it. It's a successful trade in my book :)
It may well go higher to $2.05(ish) today or soon, but the IBB started to slip once it hit $235, so just in case, ETRM followed, I sold. I can re-enter late if I wish. Plenty of time before catalyst.
Status Filled at $1.9201
Symbol ETRM
Description ENTEROMEDICS INC COM NEW
Action Sell
Quantity 5,300 Shares
Route FDLM
Order Type Trailing Stop Limit at $1.92
Trail Amount $0.02 Based on Last
Market Session Standard
Order Date 04/22/2014, 10:40:31 AM ET
Cancel Date
Order Number D22NTTW
Good stuff here hesse. Thanks. We always need reminders and to re-think our strategies, adapt, and stay focused.
OT: Smurfheads Rollcall - Status Updates???
horent, fam, azy, andrew, hesse (others i missed?) - what's moving for your holdings - what's on the watchlist - thoughts? - how we doing?
I am holding ELTP, ETRM, IDRA (ouch), SYN. Am still looking to scratch and claw my way back to even on holdings. That would be a major victory for the month if I'm able to do so. Will be holding SYN through data release unless there's a huge move before then and some can be taken off the table. Hoping all is well with Smurf.
ELTP - Patent Granted - PR
(note: IMO - I don't expect this to do much of anything for the stock price, as it was known coming - but its better then it NOT being issued :)
ELITE PHARMACEUTICALS GRANTED NEW PATENT FOR ABUSE DETERRENT TECHNOLOGY
NORTHVALE, N.J. – April 22, 2014 – Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB: ELTP) announced today the issuance of U.S. Patent No. 8,703,186 titled "Abuse-Resistant Oral Dosage Forms and Method of Use Thereof”. This patent expands the intellectual property for the Company’s opioid abuse deterrent technology. Elite now has three US patents and one Canadian patent issued in this area with additional patents pending in the U.S., Canada and Europe.
"We are pleased with this additional patent coverage,” stated Nasrat Hakim, President and CEO of Elite. "Elite’s abuse deterrent program has made significant progress. In December, a successful pilot bioequivalence study for ELI-201 was completed and in January a successful pivotal bioequivalence study for ELI-200 was completed. These products are the first of our many abuse deterrent opioid products under development.”
About Elite’s Abuse Deterrent Technology
Elite’s abuse deterrent products utilize the Company’s proprietary pharmacological abuse deterrent technology. Elite’s abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
About Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. Elite's strategy includes assisting partner companies in the life cycle management of products to improve off-patent drug products and developing generic versions of controlled release drug products with high barriers to entry. Elite has seven commercial products currently being sold, twelve additional approved products pending manufacturing site transfer and two additional products under review pending approval by the FDA. Elite’s lead pipeline products include abuse resistant opioids utilizing the Company’s patented proprietary technology, and a once-daily opioid. They are sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse. Elite also provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.) and has partnered with Epic Pharma for the manufacturing and distribution of eleven approved products pending manufacturing site, with Hi-Tech Pharmacal to develop an intermediate for a generic product, and a Hong Kong based company to develop a branded product for the United States market and its territories. Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ.
This news release contains "forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Including those related to the effects, if any, on future results, performance or other expectations that may have some correlation to the subject matter of this press release, readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, its ability to obtain FDA approval of the transfers of the ANDAs or the timing of such approval process, delays, uncertainties, inability to obtain necessary ingredients and other factors not under the control of Elite, which may cause actual results, performance or achievements of Elite to be materially different from the results, performance or other expectations that may be implied by these forward-looking statements. These risks and other factors, including, without limitation, the Company’s ability to obtain sufficient funding under the LPC Agreement or from other sources, the timing or results of pending and future clinical trials, regulatory reviews and approvals by the Food and Drug Administration and other regulatory authorities, intellectual property protections and defenses, and the Company’s ability to operate as a going concern, are discussed in Elite's filings with the Securities and Exchange Commission, including its reports on forms 10-K, 10-Q and 8-K. Elite undertakes no obligation to update any forward-looking statements.
Contact:
Elite Pharmaceuticals, Inc.
Dianne Will, Investor Relations, 518-398-6222
Dianne@elitepharma.com
POZN $9.20 - Strong Move past resistance - Good News for Bio Barometer. POZN breaks resistance 4-5 days before catalyst. Watch SYN (also made a 14% move yesterday) also to see how these plays move into their catalysts, and how it affects YOUR holdings. If POZN comes back down to upper 8.90's - it'd be a good play to buy and flip before 4/25.
Upcoming Catalyst on 4/25 or before - PDUFA
link: http://www.fool.com/investing/general/2014/04/21/3-biotech-stocks-with-upcoming-catalysts.aspx
Pozen is seeking approval for its aspirin therapies for cardiovascular disease
Pozen is expecting to hear word from the FDA about its aspirin therapies PA8140/PA32540 by April 25. The therapies are designed to reduce gastric ulcers for patients taking aspirin as part of a daily regimen to reduce the risk of cardiovascular disease. Previously, Pozen's therapies were set for FDA review in January, but the date was pushed back to April after the FDA requested a bio-availability study between PA32540 and PA8140. The company announced earlier this month that the study has been finished and submitted to the FDA, completing its NDA. So, without any further delays, we should know the drugs' collective fate this week.
What's important to know is that Pozen has partnered with Sanofi for these therapies, entitling them to milestone and royalty payments moving forward. Sanofi will be responsible for launching the drugs in the U.S., which could happen as early as the third quarter of this year.
Overall, I'm not concerned as much about the approval of these drugs as I am about what they mean to Pozen's bottom line. The deal it inked with Sanofi won't trigger any milestone payments large enough to be viewed as game-changers -- partly because of the commercial issues with Pozen's other proton pump inhibitor Vimovo. So, you may want to look elsewhere for more profitable catalysts in the biotech arena.
Thanks - Good things to consider. I have been looking this month to get even from underwater and that's pretty much the only goal. Any profits are a bonus - if they occur.
Then once current positions are cleared, will only enter very short term trades (hours to a few days).
I will pull up a post (when I can find it) about comparing consumer discretionaries vs. staples and how they moved to confirm/predict the last 2-3 market crashes. i found it very compelling and interesting and saved it to watch. Will do so this week (someone remind me later if I don't).
The last 3-4 data presentations I held (not SYN though), data was PR'd in the AM before. Am expecting good news, otherwise... why a two day presentation?
horent, Remember to wait for the price that you want, and if it doesn't hit, then so be it.
IMO, right now it's a buyer's market, with so many to choose from. No reason to hurry into any trade.
I am reminding myself of this all the time. Best of Luck.
Yes, everything has changed (at least temporarily). Adapt or be left behind.
My brother said in California (he's in Sacramento) that as long as you're not being rowdy, blatant about it, or causing probs, that cops will ignore it in public.
I'm in Wisconsin, its been on the ballot a few times and hasn't passed. I believe it would help me greatly so hoping it will pass soon. I'd much rather use that.
OT: MedChart - I believe the paid version ($2-$3) allows you to setup multiple users, etc. The only bug i found is that the year date didn't roll over to the next year, but that's not really important to me.
Yes, SYN data, and QRXPY should be followed closely too. QRXPY was halted today I believe (for their ADCOM).
Greed will return, we know that. I believe the only catalyst really has been MNKD during this BIO selloff?
Once 1 or 2 of these bios make a 20-50% move, greed will flow back in.
Unfortunately, only back in small amounts, mobility is still very limited. Is what it is and trying to find a way to fight around it all. One has to learn to adapt.
On the plus side, maybe I can become a test patient for ELTP or DARA's products. Or maybe move to Colorado and open up a weed shop :)
MSTX APP - It looks like a pretty cool app. I have a similar but very basic app that I use to track my Pain levels and Meds i take so I don't forget when I last took them, and also when I go to the doctor, I just email my history and print it out so he can easily see.
Side note: for any parents - I also use my app to track when i give meds to kids/ their temps, and other events (cough, vomiting, bad headaches, etc.). It's of great help when/if you need to go to the doc and remember when their symptoms first appeared.
The app I use is a free one called MedChart (android) if anyone is interested.
POZN $8.73 : Barometer of a Bio with very near term catalyst.
POZN has a PDUFA date of 4/25 (one week away) and to me, is a good barometer of sentiment of how an individual BIO with a short term catalyst reacts with/against the IBB/XBI. I have in the chart below, the IBB in pink behind the price so you can see how POZN has moved vs. the IBB.
I have no positions in POZN and don't plan to have any at the moment (unless I see a Bear raid and have cash), but I WILL be watching it to see how it performs vs other BIOS with near term catalysts, and other Bios overall. Sentiment has changed for the Bios IMO, however greed never changes, it just moves from sector to sector. In the past, it seemed to me that one could enter a catalyst date a few months ahead of time, and wait. At the moment, that system doesn't seem to be working, and timeframes may have changed. When I exit my current positions, I'll be looking to enter into new positions on quick trades.
Watching POZN to see if it has strength and/or runs up in the next week, to see if it will break resistance ($8.75-$9) BEFORE the PDUFA, and to see once its approved/denied - how high/low it goes and just how quickly it sells off.
OT: Still dealing with a lot of problems with my spine / neck and the wonderful new meds that they give me to make it better (said in a sarcastic tone).
I'm kinda like the IBB :) Down, but not out. Just have to wait and hope for better days.
Holding the following, as they have reasons to believe still:
SYN : April 29 data due - 8 or 9 trading days left
ELTP : Patent news coming next week, trial initiation news, etc.
ETRM : ADCOM in June, Completion of using ATM
IDRA : Well, I have to review this one when i'm able. It's reasons may be too far off, but can average down or cut it.
Haven't followed too closely but watching LJPC, ACST, ADMP, MSTX and i'm sure there's a whole bunch others that got whacked too for when this settles.
Remember to re-evaluate your holdings daily/weekly for reasons to believe. Best of Luck to all and hope to re-start my trading (and other) life again soon.
ELTP $.31 - At least the volume is picking up again? (how is that for positive thinking?)
It may be a problem of missed expectations with the trial delay, etc. People get tired of waiting and fear creeps in as to why. Just a thought. Am thinking of selling something for a small loss and averaging down into it, but will wait a bit still before doing so.
RGDX - $1.24 - Nearing Gap at $1.20. It had the highest volume ever a few days ago and shot up to $1.56 before it sold off and then the Bio tank job. No available cash for me, but on watch anyway. I'd personally wait for it to fill the gap, and then move below the gap before an entry, but that's me.
NVAX - hesse, I'm not sure if you saw this or not, so just in case:
Excerpt: One of our favorite insider buying markers is cluster buying. That's when multiple executives and directors at the company decide to buy at the same time. Last week four members of the NVAX team bought a total of 90,000 shares valued at $392,199, which puts the dollar cost average of the purchases at $4.36; slightly lower than today's price.
full article link: http://www.istockanalyst.com/finance/story/6792505/novavax-inc-nvax-four-insider-buyers-with-a-history-of-getting-it-right
ELTP - Updates from a post from ELTP's iHub Board. I have no idea if any of this information is valid / truthful or not. So, reader beware, but it is quite detailed.
I've been waiting on a few PR's to be released, trial info, patent info (april 22nd I believe now is the date), to help give this a pop.
Something to think about at least.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=100195925
Very sorry to hear about your grandfather. It's a always a tough loss. Only good thing at the moment is that you had a chance to know him in your life and from what it seems, some of your children also get to know him also.
IRDA - Yup - Thanks. I knew they were going to release info at the presentation and figured it was going to be supportive. I'll be holding until it gets back up to near where I bought in before the BIOs tanking.
It moves pretty much "step by step" with the IBB since I have been watching it over the last few weeks. So, hoping that's still the case and it'll move fast too on a bounce.
Nope, haven't had a chance to watch much of anything. Been a rough last month for me.